Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Darbepoetin Alfa Risks Outweigh Benefits for Patients With CKD, Diabetes, and Anaemia: Presented at Renal Week 2009 - (DGDispatch)
    Fenofibrate May Protect Diabetics Against Loss of Renal Function: Presented at Renal Week 2009 - (DGDispatch)
    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - (N Engl J Med)
    TopAbstracts in Diabetes 11/03/2009 - (DGNews)
    Paricalcitol Added to Hypertension Therapy Lowers Albuminuria in Patients With Diabetes and Chronic Kidney Disease: Presented at Renal Week 2009 - (DGDispatch)

    News archive

     Recent webcasts/CME - Diabetes
    • Optimizing Insulin-Dependent Diabetes Management in Long-Term Care
    • Insulin-Dependent Diabetes in Long-Term Care: Scope of the Problem and Effective Management
    • Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
      Diabetes Management - Pearls of Lipid Control
      Obesity Management in Patients with Type 2 Diabetes

      Webcasts/CME archive

       Recent cases - Diabetes
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy
        Compound Heterozygous Mutation of Aquaporin 2 Gene in Woman Patient with Congenital Nephrogenic Diabetes Insipidus

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Heavy Proteinuria May Speed Progression Of Diabetic Nephropathy

        A DGReview of :"Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy."
        Journal of Diabetes and its Complications

        01/13/2003
        By David Loshak


        Heavy proteinuria may quicken the progression of diabetic nephropathy, say researchers.

        The process may be a result of the increase in the expression of monocyte chemoattractant protein-1 in renal tubuli, say investigators at Akita University School of Medicine, Akita, Japan.

        Monocyte chemoattractant protein-1 is a chemokine which mediates renal interstitial inflammation, tubular atrophy and interstitial fibrosis. It does so by recruiting monocytes and macrophages into renal tubulointerstitium.

        The investigators noted that recent studies had shown that protein overload in renal tubular cells up-regulated monocyte chemoattractant protein-1 gene and its protein expression.

        They then put forward the idea that increased expression of monocyte chemoattractant protein-1 in renal tubuli, probably triggered by increased leakage of plasma protein from glomerular capillary to tubular fluid, might contribute to renal tubular damage and accelerate diabetic nephropathy.

        The investigators examined urinary excretion levels of monocyte chemoattractant protein-1and N-acetylglucosaminidase, a sensitive marker of renal tubular damage, in 72 Japanese Type II diabetic patients. Twenty nine had normoalbuminuria, 25 had microalbuminuria and 18 had macroalbuminuria.

        The median urinary excretion level of monocyte chemoattractant protein-1 in patients with macroalbuminuria was 394.4 ng/g creatinine, significantly higher than the levels in patients with normoalbuminuria (159.6 ng/g creatinine) and microalbuminuria (193.9 ng/g creatinine). Moreover, urinary monocyte chemoattractant protein-1 excretion level was positively correlated with urinary excretion levels of albumin and N-acetylglucosaminidase in all patients.

        The investigators said that these findings suggested that monocyte chemoattractant protein-1 was produced in renal tubular cells and released into urine in proportion to the degree of proteinuria (albuminuria).
        Journal of Diabetes and its Complications 2003;17(1):11-15. "Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send